Impact of Thyroid Immune-Related Adverse Events on Clinical Outcomes in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Checkpoint Inhibitor Therapy: A Single Center Study. Biomol Biomed 2025. https://doi.org/10.17305/bb.2025.12321.